Stephen Sikorski
Family Medicine · Westminster, MDNPI 1710063359
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 330 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,885 and has fallen 98.9% since, to $21 in 2025. Among family medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 330 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$854
- Astellas Pharma US Inc$662
- Boehringer Ingelheim$516
- AstraZeneca$443
- Novo Nordisk$353
- Amarin Pharma, Inc.$323
- plus $3K from 23 others
What the payments were for
- Food & beverage$5,34995%
- Education$3075%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $854 |
| Astellas Pharma US Inc | 28 | $662 |
| Boehringer Ingelheim | 30 | $516 |
| AstraZeneca | 18 | $443 |
| Novo Nordisk | 23 | $353 |
| Amarin Pharma, Inc. | 17 | $323 |
| Merck | 21 | $267 |
| Lilly USA, LLC | 16 | $241 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $235 |
| Esperion Therapeutics, Inc. | 9 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $185 |
| GSK | 11 | $181 |
| Grifols USA, LLC | 7 | $166 |
| Johnson & Johnson | 8 | $161 |
| Biohaven Pharmaceuticals, Inc. | 10 | $154 |
| Pfizer | 9 | $130 |
| Sunovion Pharmaceuticals Inc. | 4 | $81 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $73 |
| Sanofi-aventis U.S. LLC | 5 | $72 |
| Amgen | 4 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Novartis | 4 | $46 |
| Eisai Inc. | 2 | $44 |
| Sanofi Pasteur Inc. | 3 | $40 |
| Dexcom, Inc. | 1 | $21 |
| PBG Puerto Rico LLC | 1 | $20 |
| Mylan Specialty L.p. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$126
How this compares
$5,656 in reported general payments places this provider in the 90th percentile of 1,193 family medicine providers in Maryland.
Other family medicine in Westminster
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
- Sanjay SaxenaHagerstown$60K
- Cynthia KleppingerSilver Spring$51K
- Tramaine DavisBowie$43K
- Alkesh PatelColumbia$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.